News
News

The latest updates from AFAR.

Grantee in News: Esther Oh research in Futurity on biomarkers for Alzheimers, common in hip fracture patients

Feb 27
2019

Grantee in News: Esther Oh research in Futurity on biomarkers for Alzheimers, common in hip fracture patients

  On February 26, 2019, Futurity featured the latest research by AFAR expert Esther Oh, MD exploring how most older people hospitalized for hip fracture surgery carried biomarkers of developing Alzheimer’s disease even though they had no clinical signs of dementia. Dr. Oh is a 2009 Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Awards in Alzheimer's Disease recipient. Read the article—“Are Hip Fractures a Flag for Alzheimer’s?”—here.


View MoreREAD MORE


Grantee in the News: S. Thomas Carmichael research on impact of missing gene on mild stroke recovery in Cell Metabolism

Feb 27
2019

Grantee in the News: S. Thomas Carmichael research on impact of missing gene on mild stroke recovery in Cell Metabolism

  On February 21, 2019, Cell Metabolism published research authored by AFAR expert S. Thomas Carmichael, MD, PhD exploring the impact of missing gene on patient recovery from a mild stroke and its implication for treatment. Dr. Carmichael is a 2005 Glenn/AFAR Grant for Junior Faculty recipient. Read the research—"CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury”—here and a related UCLA press release here.  


View MoreREAD MORE


Grantee in the News: Matt Kaeberlein affirms FDA caution on young blood transfusion in STAT News

Feb 22
2019

Grantee in the News: Matt Kaeberlein affirms FDA caution on young blood transfusion in STAT News

  On February 19, 2019, STAT News featured insights of AFAR expert Matt Kaeberlein, PhD in an article affirming the FDA’s recent warning against the rise of private companies promoting young blood transfusions to target age-related diseases. Dr. Kaeberlein is a 2007 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award recipient and Co-Director of the Nathan Shock Center of Excellence in the Biology of Aging at the University of Washington, for which AFAR serves as the Coordinating Center. Read the article “FDA: Young-bloodtransfusions provide ‘no proven clinical benefit’ for aging, Alzheimer’s” here. Read…


View MoreREAD MORE


Experts in the News: Campisi, Kirkland, and Musi in MIT Technology Review on early senolytics trial in humans

Feb 15
2019

Experts in the News: Campisi, Kirkland, and Musi in MIT Technology Review on early senolytics trial in humans

  On February 13, 2019, MIT Technology Review featured insights from AFAR experts Judy Campisi, PhD, James L. Kirkland, MD, PhD, and Nicholas Musi, MD on the first human test of senolytic drugs that could help decrease the impact of age-related diseases. Dr. Campisi is a 1990 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient. Dr. Kirkland is AFAR’s Board President-Elect and a 2012 Glenn/AFAR Breakthroughs in Gerontology (BIG) Award recipient. Dr. Musi is 2007 Beeson Scholar and has served on AFAR’s National Scientific Advisory Council. Additionally, Dr. Musi is co-leader of the Healthspan and Functional…


View MoreREAD MORE


Grantee in the News: Kristine Yaffe on sleep patterns and healthy aging in Washington Post

Feb 15
2019

Grantee in the News: Kristine Yaffe on sleep patterns and healthy aging in Washington Post

  On February 10, 2019,  The Washington Post featured insights from AFAR expert Kristine Yaffe, MD in an article on sleep patterns and health as we age. Dr. Yaffe is a 2001 Paul B. Beeson Emerging Leaders Career Development Award in Aging Scholar. Read “Sleep patterns can change with aging. Does that mean health troubles ahead?” here.  


View MoreREAD MORE


Grantees in the News: Research in Nature co-authored by 3 AFAR experts on HIV drug that reduces age-related disorders

Feb 13
2019

Grantees in the News: Research in Nature co-authored by 3 AFAR experts on HIV drug that reduces age-related disorders

  On February 6, 2019, Nature published research co-authored by AFAR experts Marco De Cecco, PhD, Vera Gorbuonova, PhD, and Steven L. Helfand, MD that found that an HIV drug significantly reduces age-related inflammation and other signs of aging in mice. Dr. De Cecco is a 2015 Glenn Foundation for Medical Research Postdoctoral Fellowship in Aging Research recipient. Dr. Gorbunova is a 2005 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty receipient. Dr. Helfand is a 2014 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award winner, 1995 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, and 1992 Glenn…


View MoreREAD MORE


Grantee in the News: Derrick Rossi research in Nature on antibody drug combination and tissue-matching in organ transplants

Feb 13
2019

Grantee in the News: Derrick Rossi research in Nature on antibody drug combination and tissue-matching in organ transplants

  On February 6, 2019, Nature published research authored by AFAR expert Derrick Rossi, PhD on an on antibody drug combination that could remove need for tissue-matching in organ transplant. Dr. Rossi is a 2015 Ellison Foundation/AFAR Julie Martin Mid‐career Award in Aging Research recipient. Although the original study--"Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation" is available by subscription only in Nature here, read a related article on Medical News here.  


View MoreREAD MORE


Grantee in the News: Reisa Sperling latest research on Sex Differences and Alzheimer’s causing protein deposits in JAMA Neurology

Feb 07
2019

Grantee in the News: Reisa Sperling latest research on Sex Differences and Alzheimer’s causing protein deposits in JAMA Neurology

  On February 4, 2018, JAMA Neurology published research authored by AFAR expert Reisa Sperling, MD, which revealed that men had fewer of tau and beta-amyloid protein deposits linked to Alzheimer’s in their brains than women. The study utilizes an innovative brain scanning technique that Dr. Sperling developed thanks to early support from AFAR. Dr. Sperling is a 2003 Beeson Scholar. Read the study—"Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured By Positron Emission Tomography in Clinically Normal Older Adults”— in JAMA Neurology here, and a related article in News Medical…


View MoreREAD MORE


Grantee in the News: Randall Bateman research in PNAS on persistent metabolic youth in aging female brain

Feb 07
2019

Grantee in the News: Randall Bateman research in PNAS on persistent metabolic youth in aging female brain

  On February 4, 2019, the Proceedings of the National Academy of Sciences published research authored by AFAR expert Randall J. Bateman, MD, which found that in terms of brain metabolism, the adult female brain is on average a few years younger than the male brain. Dr. Bateman is 2007 Beeson Scholar, as well as recipient of the 2012 MetLife Foundation Promising Investigator Award for Medical Research in Alzheimer’s Disease, which AFAR managed. Read “Persistent metabolic youth in the aging female brain” here.  


View MoreREAD MORE




BACK TO TOPBACK TO TOP